{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:21:55Z","timestamp":1793294515890,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T00:00:00Z","timestamp":1601596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>The aim of our study was to describe microbial flora associated with MRONJ and characterize the susceptibility of pathogens to help guide an effective empiric antibiotic treatment in these patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>A retrospective, single-center analysis was performed, using 116 bone samples from 98 patients. The bone samples were homogenized and subjected to routine culture methods. Growing bacteria were differentiated to the species level using whole-cell mass spectrometry and subjected to susceptibility testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A highly diverse microbial flora was detected in necrotic bone, with a simultaneous presence of two or more bacterial species in 79% of all patients. In at least 65% of samples, gram-negative isolates were detected. Therefore, bacterial species resistant against \u03b2-lactamase inhibitors were present in at least 70% of all patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The empiric choice of antibiotics in MRONJ patients should consider the high rate of gram-negative bacteria and resistance against \u03b2-lactam antibiotics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Clinical relevance<\/jats:title>\n                <jats:p>According to recent guidelines and recommendations, systemic antibiotic treatment is a key component in the treatment of all stage 2 and 3 MRONJ patients. We recommend using fluoroquinolones for empiric treatment and emphasize the use of bacterial cultivation and susceptibility testing to enable an effective antibiotic treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00784-020-03595-9","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T04:29:13Z","timestamp":1601612953000},"page":"2801-2809","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ)"],"prefix":"10.1007","volume":"25","author":[{"given":"Florian","family":"Ewald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Wuesthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Koehnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard E.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Gosau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-1798","authenticated-orcid":false,"given":"Alexandre T.","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"3595_CR1","first-page":"3917","volume":"33","author":"AT Assaf","year":"2013","unstructured":"Assaf AT, Smeets R, Riecke B, Weise E, Grobe A, Blessmann M, Steiner T, Wikner J, Friedrich RE, Heiland M et al (2013) Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies. Anticancer Res 33:3917\u20133924","journal-title":"Anticancer Res"},{"key":"3595_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.11622\/smedj.2018014","volume":"59","author":"BH Chan","year":"2018","unstructured":"Chan BH, Yee R, Puvanendran R, Ang SB (2018) Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management. Singapore Med J 59:70\u201375","journal-title":"Singapore Med J"},{"key":"3595_CR3","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1056\/NEJMp068157","volume":"355","author":"JP Bilezikian","year":"2006","unstructured":"Bilezikian JP (2006) Osteonecrosis of the jaw--do bisphosphonates pose a risk? N Engl J Med 355:2278\u20132281","journal-title":"N Engl J Med"},{"key":"3595_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/jcpe.12882","volume":"45","author":"M Diniz-Freitas","year":"2018","unstructured":"Diniz-Freitas M, Fernandez-Feijoo J, Diz Dios P, Pousa X, Limeres J (2018) Denosumab-related osteonecrosis of the jaw following non-surgical periodontal therapy: a case report. J Clin Periodontol 45:570\u2013577","journal-title":"J Clin Periodontol"},{"key":"3595_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jormas.2017.12.009","volume":"119","author":"H Compain","year":"2018","unstructured":"Compain H, Berquet A, Loison-Robert LS, Ahossi V, Zwetyenga N (2018) Duration of treatment with bisphosphonates at the time of osteonecrosis of the jaw onset in patients with rheumatoid arthritis. Review. J Stomatol Oral Maxillofac Surg 119:177\u2013181","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"3595_CR6","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL (2018) Medication-related osteonecrosis of the jaw: an update on the memorial Sloan Kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral Surg Oral Med Oral Pathol Oral Radiol 125:440\u2013445","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"3595_CR7","first-page":"32","volume":"e23","author":"CC De Antoni","year":"2018","unstructured":"De Antoni CC, Matsumoto MA, Silva AAD, Curi MM, Santiago Junior JF, Sassi LM, Cardoso CL (2018) Medication-related osteonecrosis of the jaw, osteoradionecrosis, and osteomyelitis: a comparative histopathological study. Braz Oral Res e23:32","journal-title":"Braz Oral Res"},{"key":"3595_CR8","doi-asserted-by":"publisher","first-page":"ed77","DOI":"10.3332\/ecancer.2018.ed77","volume":"12","author":"O Nicolatou-Galitis","year":"2018","unstructured":"Nicolatou-Galitis O, Migliorati C (2018) Osteonecrosis of the jaw (ONJ) in patients who receive bone targeting agents (BTAs): the power of e-learning. Ecancermedicalscience 12:ed77","journal-title":"Ecancermedicalscience"},{"key":"3595_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev.med.60.063007.134350","volume":"60","author":"SL Ruggiero","year":"2009","unstructured":"Ruggiero SL, Mehrotra B (2009) Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management. Annu Rev Med 60:85\u201396","journal-title":"Annu Rev Med"},{"key":"3595_CR10","first-page":"724","volume":"118","author":"B Galis","year":"2017","unstructured":"Galis B, Zajko J, Hirjak D, Vanko L, Kupcova I, Jurkemik J, Gengelova P, Mikuskova K, Halmova K, Riznic M, Czako L (2017) Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease. Bratisl Lek Listy 118:724\u2013731","journal-title":"Bratisl Lek Listy"},{"key":"3595_CR11","doi-asserted-by":"crossref","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral and Maxillofacial Surgeons: American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"3595_CR12","doi-asserted-by":"publisher","first-page":"20170323","DOI":"10.1259\/dmfr.20170323","volume":"47","author":"A Baba","year":"2018","unstructured":"Baba A, Goto TK, Ojiri H, Takagiwa M, Hiraga C, Okamura M, Hasegawa S, Okuyama Y, Ogino N, Yamauchi H et al (2018) CT imaging features of antiresorptive agent-related osteonecrosis of the jaw\/medication-related osteonecrosis of the jaw. Dentomaxillofac Radiol 47:20170323","journal-title":"Dentomaxillofac Radiol"},{"key":"3595_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiodt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177\u2013187","journal-title":"Cancer Treat Rev"},{"key":"3595_CR14","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.jcms.2015.06.025","volume":"43","author":"AT Assaf","year":"2015","unstructured":"Assaf AT, Zrnc TA, Remus CC, Adam G, Zustin J, Heiland M, Friedrich RE, Derlin T (2015) Intraindividual comparison of preoperative (99 m)Tc-MDP SPECT\/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw. J Craniomaxillofac Surg 43:1461\u20131469","journal-title":"J Craniomaxillofac Surg"},{"key":"3595_CR15","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.archoralbio.2014.05.002","volume":"59","author":"RC Boff","year":"2014","unstructured":"Boff RC, Salum FG, Figueiredo MA, Cherubini K (2014) Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws. Arch Oral Biol 59:790\u2013799","journal-title":"Arch Oral Biol"},{"key":"3595_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.oooo.2017.11.022","volume":"125","author":"L De Bruyn","year":"2018","unstructured":"De Bruyn L, Coropciuc R, Coucke W, Politis C (2018) Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics. Oral Surg Oral Med Oral Pathol Oral Radiol 125:268\u2013275","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"3595_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.joms.2014.10.035","volume":"73","author":"HC Schwartz","year":"2015","unstructured":"Schwartz HC (2015) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX. J Oral Maxillofac Surg 73:377","journal-title":"J Oral Maxillofac Surg"},{"key":"3595_CR18","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H et al (2019) Medication-related osteonecrosis of the jaw: MASCC\/ISOO\/ASCO Clinical Practice Guideline. J Clin Oncol 37:2270\u20132290","journal-title":"J Clin Oncol"},{"key":"3595_CR19","doi-asserted-by":"publisher","first-page":"8071579","DOI":"10.1155\/2018\/8071579","volume":"2018","author":"K Pimolbutr","year":"2018","unstructured":"Pimolbutr K, Porter S, Fedele S (2018) Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-naive patient: a comprehensive review of the literature. Biomed Res Int 2018:8071579","journal-title":"Biomed Res Int"},{"key":"3595_CR20","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1080\/10428190802483778","volume":"49","author":"V Montefusco","year":"2008","unstructured":"Montefusco V, Gay F, Spina F, Miceli R, Maniezzo M, Teresa Ambrosini M, Farina L, Piva S, Palumbo A, Boccadoro M, Corradini P (2008) Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leuk Lymphoma 49:2156\u20132162","journal-title":"Leuk Lymphoma"},{"key":"3595_CR21","unstructured":"Schiegnitz E, Al-Nawas, B, Hoefert, S, Otto, S, Pautke, C, Ristow, O, Voss, P, Gr\u00f6tz, KA: S3-Leitlinie Antiresorptiva-assoziierte Kiefernekrosen (AR-ONJ). 2012"},{"key":"3595_CR22","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1600-051X.1998.tb02419.x","volume":"25","author":"SS Socransky","year":"1998","unstructured":"Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr (1998) Microbial complexes in subgingival plaque. J Clin Periodontol 25:134\u2013144","journal-title":"J Clin Periodontol"},{"key":"3595_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jcms.2017.01.006","volume":"45","author":"S Panya","year":"2017","unstructured":"Panya S, Fliefel R, Probst F, Troltzsch M, Ehrenfeld M, Schubert S, Otto S (2017) Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ). J Craniomaxillofac Surg 45:357\u2013363","journal-title":"J Craniomaxillofac Surg"},{"key":"3595_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A, James Kirkpatrick C (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155\u2013160","journal-title":"J Oral Pathol Med"},{"key":"3595_CR25","first-page":"w13605","volume":"142","author":"C Jacobsen","year":"2012","unstructured":"Jacobsen C, Metzler P, Obwegeser JA, Zemann W, Graetz KW (2012) Osteopathology of the jaw associated with bone resorption inhibitors: what have we learned in the last 8 years? Swiss Med Wkly 142:w13605","journal-title":"Swiss Med Wkly"},{"key":"3595_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1128\/CMR.00100-14","volume":"28","author":"E Kononen","year":"2015","unstructured":"Kononen E, Wade WG (2015) Actinomyces and related organisms in human infections. Clin Microbiol Rev 28:419\u2013442","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3595_CR27","doi-asserted-by":"publisher","first-page":"e02462","DOI":"10.1128\/AAC.02462-18","volume":"63","author":"GT Walker","year":"2019","unstructured":"Walker GT, Quan J, Higgins SG, Toraskar N, Chang W, Saeed A, Sapiro V, Pitzer K, Whitfield N, Lopansri BK et al (2019) Predicting antibiotic resistance in gram-negative bacilli from resistance genes. Antimicrob Agents Chemother 63(4):e02462\u201318","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03595-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00784-020-03595-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-020-03595-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T00:05:12Z","timestamp":1633133112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00784-020-03595-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["3595"],"URL":"https:\/\/doi.org\/10.1007\/s00784-020-03595-9","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"value":"1432-6981","type":"print"},{"value":"1436-3771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was waived by the local Ethics Committee of University Hamburg Medical Center in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}